DAY 1 (1:30 PM ET) What is your biggest barrier to automating signal detection?
Identifying new potential risks for a products safety profile is at the heart of all PV activities. But a product's safety profile is rarely static due to increased exposure, new or untested drug-drug interaction and pharmacogenetic variations, to name a few. The industry needs to move from manual traditional methods to more automated quantitative methods.
What is your biggest barrier to automating signal detection?
Select your top activity from the options below, or add as a comment.
Join us at 1:30PM–2:30PM ET for a lively panel discussion on The future of signaling.
Not yet registered for Health Sciences Connect 2022? Register here.